ZJYL

+ Watchlist + Portfolio

JIN MEDICAL INTERNATIONAL LTD.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.00
52-Week Range: $1.53 – $12.00
Market Cap: $144.85M
P/E (TTM): 10.21
EPS (TTM): 0.19
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.50
PEG Ratio: —
Return on Equity: 4.02%
Return on Assets: 0.50%
Gross Margin: 31.28%
Operating Margin: -7.22%
Profit Margin: 5.95%
Current Ratio: 1.95
Debt/Equity: 0.69
Total Debt: $20.90M
Free Cash Flow: $-7.49M
Revenue Growth: -9.70%
Earnings Growth: —
Enterprise Value: $142.79M

ZJYL Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$19.19M	$19.82M	$23.50M	$20.69M
Cost of Revenue	$12.99M	$13.04M	$14.00M	$14.64M
Gross Profit	$6.20M	$6.78M	$9.50M	$6.04M
Research & Development	$1.89M	$1.54M	$1.50M	$1.56M
Selling, General & Admin	$2.18M	$2.37M	$4.37M	$3.88M
Operating Expenses	$4.07M	$3.92M	$5.86M	$5.44M
Operating Income	$2.13M	$2.87M	$3.64M	$608.18K
EBITDA	$2.49M	$3.09M	$3.98M	$958.86K
Pretax Income	$2.74M	$3.22M	$4.18M	$1.60M
Income Tax	$36.11K	$343.71K	$763.88K	$214.57K
Net Income	$2.71M	$2.88M	$3.68M	$1.19M
Diluted EPS	0.36	0.40	0.40	0.20
Diluted Shares	7.50M	7.26M	7.82M	7.83M

ZJYL Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$4.79M	$6.93M	$8.14M	$7.46M
Receivables	$4.25M	$8.50M	$8.78M	$6.80M
Inventory	$6.72M	$5.05M	$5.17M	$4.92M
Current Assets	$18.90M	$31.12M	$42.82M	$44.14M
Total Assets	$20.94M	$32.90M	$45.80M	$53.37M
Current Liabilities	$5.70M	$8.92M	$17.15M	$23.80M
Total Debt	—	$4.11M	$11.60M	$18.91M
Total Liabilities	$5.70M	$8.92M	$17.25M	$23.80M
Retained Earnings	$14.41M	$16.93M	$20.02M	$20.94M
Shareholders' Equity	$15.24M	$23.98M	$28.82M	$29.64M
Working Capital	$13.20M	$22.19M	$25.66M	$20.35M
Net Debt	—	—	$3.19M	$11.38M

ZJYL Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$1.58M	$3.11M	-$1.21M	$2.90M
Capital Expenditure	-$40.17K	-$113.94K	-$1.12M	-$6.63M
Free Cash Flow	$1.54M	$2.99M	-$2.33M	-$3.73M
Depreciation & Amortisation	$362.60K	$225.90K	$346.13K	$350.68K
Investing Cash Flow	-$120.90K	-$7.73M	-$9.51M	-$10.79M
Financing Cash Flow	$121.86K	$6.91M	$11.65M	$7.35M
Net Change in Cash	$1.58M	$2.29M	$933.04K	-$534.91K

ZJYL Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q3 2025	Q1 2026
Cash & Equivalents	$11.13M	$7.46M	$9.08M
Receivables	$6.14M	$6.80M	$6.65M
Inventory	$4.46M	$4.92M	$5.75M
Current Assets	$43.78M	$44.14M	$44.56M
Total Assets	$48.52M	$53.37M	$55.84M
Current Liabilities	$20.74M	$23.80M	$22.82M
Long-Term Debt	—	—	$2.87M
Total Debt	$15.92M	$18.91M	$20.90M
Total Liabilities	$20.77M	$23.80M	$25.69M
Retained Earnings	$19.86M	$20.94M	$20.83M
Shareholders' Equity	$27.91M	$29.64M	$30.32M
Working Capital	$23.04M	$20.35M	$21.73M
Net Debt	$4.59M	$11.38M	$11.76M

Market Snapshot

About

Jin Medical International Ltd. is a medical device company specializing in orthopedic and trauma products. The company develops, manufactures, and distributes medical devices primarily in Asian markets. Jin Medical focuses on innovative solutions for bone and joint treatments.